These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39154664)

  • 1. Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction.
    Du Y; Wang D; Katis VL; Zoeller EL; Qui M; Levey AI; Gileadi O; Fu H;
    SLAS Discov; 2024 Sep; 29(6):100177. PubMed ID: 39154664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Time-Resolved Fluorescence Resonance Energy Transfer ultra-high throughput screening assay for targeting SYK and FCER1G interaction.
    Du Y; Wang D; Katis VL; Zoeller EL; Qui M; Levey AI; Gileadi O; ; Fu H
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
    Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
    Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors.
    Du Y; Fu RW; Lou B; Zhao J; Qui M; Khuri FR; Fu H
    Assay Drug Dev Technol; 2013 Jul; 11(6):367-81. PubMed ID: 23906346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.
    Bashore FM; Katis VL; Du Y; Sikdar A; Wang D; Bradshaw WJ; Rygiel KA; Leisner TM; Chalk R; Mishra S; Williams CA; Gileadi O; Brennan PE; Wiley JC; Gockley J; Cary GA; Carter GW; Young JE; Pearce KH; Fu H; ; Axtman AD
    PLoS One; 2024; 19(2):e0293548. PubMed ID: 38359047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.
    Bashore FM; Katis VL; Du Y; Sikdar A; Wang D; Bradshaw WJ; Rygiel KA; Leisner TM; Chalk R; Mishra S; Williams AC; Gileadi O; Brennan PE; Wiley JC; Gockley J; Cary GA; Carter GW; Young JE; Pearce KH; Fu H; ; Axtman AD
    bioRxiv; 2023 Jul; ():. PubMed ID: 37547005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4-SMAD3-DNA complex.
    Ouyang W; Li Q; Niu Q; Qui M; Fu H; Du Y; Mo X
    J Mol Cell Biol; 2024 Apr; 15(11):. PubMed ID: 37968137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
    Kim TG; Lee JH; Lee MY; Kim KU; Lee JH; Park CH; Lee BH; Oh KS
    Biol Pharm Bull; 2017; 40(9):1454-1462. PubMed ID: 28867728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2.
    Wyhs N; Walker D; Giovinazzo H; Yegnasubramanian S; Nelson WG
    J Biomol Screen; 2014 Aug; 19(7):1060-9. PubMed ID: 24608100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for the Inhibition of Keap1-Nrf2 Protein-Protein Interaction.
    Lee S; Abed DA; Beamer LJ; Hu L
    SLAS Discov; 2021 Jan; 26(1):100-112. PubMed ID: 32564647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitors.
    Madiraju C; Welsh K; Cuddy MP; Godoi PH; Pass I; Ngo T; Vasile S; Sergienko EA; Diaz P; Matsuzawa S; Reed JC
    J Biomol Screen; 2012 Feb; 17(2):163-76. PubMed ID: 22034497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS.
    Cicka D; Niu Q; Qui M; Qian K; Miller E; Fan D; Mo X; Ivanov AA; Sarafianos SG; Du Y; Fu H
    J Mol Cell Biol; 2023 Aug; 15(3):. PubMed ID: 36921991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A time-resolved fluorescence resonance energy transfer assay suitable for high-throughput screening for inhibitors of immunoglobulin E-receptor interactions.
    Kim B; Tarchevskaya SS; Eggel A; Vogel M; Jardetzky TS
    Anal Biochem; 2012 Dec; 431(2):84-9. PubMed ID: 22995065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel high-throughput screening assay for discovery of molecules that increase cellular tetrahydrobiopterin.
    Li L; Du Y; Chen W; Fu H; Harrison DG
    J Biomol Screen; 2011 Sep; 16(8):836-44. PubMed ID: 21693765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a FOXM1-DBD Binding Assay for High-Throughput Screening Using TR-FRET Assay.
    Lee MY; Haam CE; Mun J; Lim G; Lee BH; Oh KS
    Biol Pharm Bull; 2021; 44(10):1484-1491. PubMed ID: 34602556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3.
    Qin Q; Knapinska A; Dobri N; Madoux F; Chase P; Hodder P; Petrukhin K
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):298-309. PubMed ID: 23098562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel scaffolds for IκB kinase beta inhibitor via a high-throughput screening TR-FRET assay.
    Oh KS; Lee S; Choi JK; Lee BH
    Comb Chem High Throughput Screen; 2010 Nov; 13(9):790-7. PubMed ID: 20615197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal.
    Zielinski T; Reichman M; Donover PS; Lowery RG
    Assay Drug Dev Technol; 2016 May; 14(4):240-51. PubMed ID: 27136323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk.
    Bakthavatsalam D; Craft JW; Kazansky A; Nguyen N; Bae G; Caivano AR; Gundlach CW; Aslam A; Ali S; Gupta S; Lin SY; Parthiban HD; Vanderslice P; Stephan CC; Woodside DG
    Front Immunol; 2020; 11():575085. PubMed ID: 33488575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.